Status:
UNKNOWN
Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
This project entitled "Impaired secretory IgA and mucosal immunity in cystic fibrosis" is a research program which aims to determine, owing to national (KULeuven) and international (Descartes universi...
Detailed Description
Impaired secretory IgA and mucosal immunity in cystic fibrosis: role of CFTR-related epithelial changes in the regulation of pIgR-mediated IgA transcytosis and contribution to lung pathology and impa...
Eligibility Criteria
Inclusion
- CF: adult CF patients (from age 18) with a classical clinical phenotype related to DF508/DF508 mutation, and colonized or not with Pseudomonas aeruginosa
Exclusion
- \<18 years
- other chronic lung diseases except COPD as a specific control subgroup
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02308267
Start Date
November 1 2015
End Date
December 1 2017
Last Update
February 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
StLuc
Brussels, Belgium, 1200